249 related articles for article (PubMed ID: 26748978)
21. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
22. Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar.
Godschalk RW; Ostertag JU; Moonen EJ; Neumann HA; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):767-73. PubMed ID: 9752984
[TBL] [Abstract][Full Text] [Related]
23. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar.
Veenhuis RT; van Horssen J; Bos RP; Anzion RB; Van Der Valk PG
Arch Dermatol Res; 2002 Jul; 294(4):168-71. PubMed ID: 12111346
[TBL] [Abstract][Full Text] [Related]
24. Droplet Digital PCR Analysis of GSTM1 Deletion Polymorphism in Psoriatic Subjects Treated with Goeckerman Therapy.
Beránek M; Fiala Z; Kremláček J; Andrýs C; Hamáková K; Palička V; Borská L
Acta Medica (Hradec Kralove); 2016; 59(3):75-78. PubMed ID: 27639151
[TBL] [Abstract][Full Text] [Related]
25. Comparison of once-daily and twice-daily ultraviolet radiation treatments in psoriasis.
Petrozzi JW; de los Reyes O
Arch Dermatol; 1981 Nov; 117(11):695-7. PubMed ID: 7316527
[TBL] [Abstract][Full Text] [Related]
26. Multiple biomarkers study in painters in a shipyard in Korea.
Lee KH; Ichiba M; Zhang J; Tomokuni K; Hong YC; Ha M; Kwon HJ; Koh SB; Choi HR; Lee KH; Park CG; Cho SH; Hirvonen A; Strickland PT; Vermeulen R; Hayes RB; Kang D
Mutat Res; 2003 Sep; 540(1):89-98. PubMed ID: 12972061
[TBL] [Abstract][Full Text] [Related]
27. Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs.
Borska L; Andrys C; Krejsek J; Palicka V; Chmelarova M; Hamakova K; Kremlacek J; Borsky P; Fiala Z
J Immunol Res; 2014; 2014():834389. PubMed ID: 24822226
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of circulating biomarkers of cell death (nucleosomes) in the patients with plaque psoriasis treated with the Goeckerman regimen.
Ranna D; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Fiala Z; Borsky P; Borska L
Bratisl Lek Listy; 2014; 115(4):229-32. PubMed ID: 24797598
[TBL] [Abstract][Full Text] [Related]
29. Comparison of calcipotriol and coal tar in conjunction with sun exposure in chronic plaque psoriasis: a pilot study.
Kaur I; Saraswat A; Kumar B
J Dermatol; 2001 Aug; 28(8):448-50. PubMed ID: 11560163
[TBL] [Abstract][Full Text] [Related]
30. DNA strand breaks, oxidative damage, and 1-OH pyrene in roofers with coal-tar pitch dust and/or asphalt fume exposure.
Toraason M; Hayden C; Marlow D; Rinehart R; Mathias P; Werren D; Olsen LD; Neumeister CE; Mathews ES; Cheever KL; Marlow KL; DeBord DG; Reid TM
Int Arch Occup Environ Health; 2001 Aug; 74(6):396-404. PubMed ID: 11563602
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis.
de Miguel R; el-Azhary R
Int J Dermatol; 2009 Jun; 48(6):653-8. PubMed ID: 19538381
[No Abstract] [Full Text] [Related]
33. The role of tar in Goeckerman therapy.
Belsito DV; Kechijian P
Arch Dermatol; 1982 May; 118(5):319-21. PubMed ID: 7082024
[TBL] [Abstract][Full Text] [Related]
34. [Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].
Borská L; Fiala Z; Smejkalová J; Hamáková K; Kremlácek J
Acta Medica (Hradec Kralove) Suppl; 2004; 47(1):19-21. PubMed ID: 15745054
[TBL] [Abstract][Full Text] [Related]
35. Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.
Borská L; Fiala Z; Krejsek J; Andrýs C; Vokurková D; Hamáková K; Kremlácek J; Ettler K
Physiol Res; 2006; 55(6):699-706. PubMed ID: 16497101
[TBL] [Abstract][Full Text] [Related]
36. Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level.
Ctirad A; Lenka B; David P; Zdenek F; Kveta H; Karel E; Jan K
Int J Dermatol; 2008 Oct; 47(10):1011-4. PubMed ID: 18986345
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
38. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
Lee E; Koo J
J Dermatolog Treat; 2005 Apr; 16(2):102-7. PubMed ID: 16019624
[TBL] [Abstract][Full Text] [Related]
39. Updating the Goeckerman regimen for psoriasis.
Petrozzi JW; Barton JO; Kaidbey KK; Kligman AM
Br J Dermatol; 1978 Apr; 98(4):437-44. PubMed ID: 638049
[TBL] [Abstract][Full Text] [Related]
40. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis.
Chern E; Yau D; Ho JC; Wu WM; Wang CY; Chang HW; Cheng YW
Acta Derm Venereol; 2011 Jun; 91(4):447-51. PubMed ID: 21537818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
